Eli Lilly could launch obesity drug in India next year
Reuters
Reuters exclusively reported that U.S. drugmaker Eli Lilly LLY.N expects to launch Mounjaro, its blockbuster diabetes drug and wildly popular obesity treatment, in India as early as next year after it clears an ongoing regulatory review.
The post Eli Lilly could launch obesity drug in India next year appeared first on Reuters News Agency.